SMG7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.109200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.764800E-01
Normal-vs-Stage2
7.987800E-01
Normal-vs-Stage3
5.462200E-01
Normal-vs-Stage4
3.765400E-01
Stage1-vs-Stage2
5.199600E-01
Stage1-vs-Stage3
2.242400E-01
Stage1-vs-Stage4
5.878800E-01
Stage2-vs-Stage3
1.418230E-01
Stage2-vs-Stage4
1.813640E-01
Stage3-vs-Stage4
1.801590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.765600E-01
Normal-vs-AfricanAmerican
2.342600E-01
Normal-vs-Asian
5.887800E-01
Caucasian-vs-AfricanAmerican
1.767410E-01
Caucasian-vs-Asian
2.312000E-01
AfricanAmerican-vs-Asian
7.771200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.631200E-01
Normal-vs-Female
9.804400E-01
Male-vs-Female
7.124100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.274800E-01
Normal-vs-Age(41-60Yrs)
5.266000E-01
Normal-vs-Age(61-80Yrs)
9.808000E-01
Normal-vs-Age(81-100Yrs)
8.240600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.580600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.956800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.529600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.062100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.087200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.393400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.154600E-01
Normal-vs-Daily Drinker
8.635200E-01
Normal-vs-Weekly Drinker
9.696800E-01
Normal-vs-Occasional Drinker
3.089200E-01
Normal-vs-Social Drinker
8.130200E-01
Non Drinker-vs-Daily Drinker
5.682600E-01
Non Drinker-vs-Weekly Drinker
8.939000E-01
Non Drinker-vs-Occasional Drinker
1.298780E-01
Non Drinker-vs-Social Drinker
9.409400E-01
Daily Drinker-vs-Weekly Drinker
7.119800E-01
Daily Drinker-vs-Occasional Drinker
2.808300E-02
Daily Drinker-vs-Social Drinker
4.859400E-01
Weekly Drinker-vs-Occasional Drinker
1.208630E-01
Weekly Drinker-vs-Social Drinker
8.303200E-01
Occasional Drinker-vs-Social Drinker
8.374400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.815610E-02
Normal-vs-Grade 2
3.743300E-03
Normal-vs-Grade 3
7.621700E-04
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.095400E-01
Grade 1-vs-Grade 3
4.611700E-02
Grade 1-vs-Grade 4
1.815610E-02
Grade 2-vs-Grade 3
2.981800E-01
Grade 2-vs-Grade 4
3.743300E-03
Grade 3-vs-Grade 4
7.621700E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.919600E-01
Normal-vs-NonDiabetic
7.048200E-01
Diabetic-vs-NonDiabetic
1.812330E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.266000E-01
Normal-vs-NoPancreatitis
8.689800E-01
Pancreatitis-vs-NoPancreatitis
4.117800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.121200E-01
Normal-vs-N1
8.980000E-01
N0-vs-N1
1.523380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.915410E-01
Normal-vs-TP53-NonMutant
7.161000E-01
TP53-Mutant-vs-TP53-NonMutant
4.523600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
